Valuation
- Market cap
- 1,133,000
- Revenue TTM
- $0
- Net income TTM
- $-35,820,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- -0.19
Trading
- Volume
- 372,200
- Avg volume
- 3,461,031
- Day's range
- $1.67 – $1.83
- Shares out
- 606,000
- Stochastic %K
- 2%
- Beta
- 0.53
- Analysts
- Strong Buy
- Price target
- —
Company profile
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed...
Show more
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 925 997 6925
- Website
- https://profusa.com
- Address
- 626 Bancroft Way, Suite A, Berkeley, United States
Latest news
No headlines yet.
